Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Carolina Piras de Oliveira"'
Autor:
Cristina da Silva Schreiber, Alex Rafacho, Renata Silverio, Roberto Betti, Antonio Carlos Lerário, Ana Maria Pita Lotenberg, Klara Rahmann, Carolina Piras de Oliveira, Bernardo Léo Wajchenberg, Protásio Lemos da Luz
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 66, Iss 3, Pp 312-323 (2022)
ABSTRACT Objectives: To evaluate the effect of sitagliptin treatment in early type 2 diabetes mellitus (T2DM) and the impact of different macronutrient compositions on hormones and substrates during meal tolerance tests (MTT). Materials and methods:
Externí odkaz:
https://doaj.org/article/344a183fdaf443e3907e8f8844a7d468
Autor:
Carolina Piras de Oliveira
Publikováno v:
Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
INTRODUÇÃO:. A dislipidemia diabética é um dos principais fatores de risco para doença arterial coronária (DAC) O uso de uma nanoemulsão LDL-símile para avaliar clearance do éster de colesterol(EC) e colesterol livre(CL) do intravascular mos
Autor:
Tim Heise, Carolina Piras de Oliveira, Rattan Juneja, Anderson Ribeiro, Farai Chigutsa, Thomas Blevins
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1689-1701
Rapid-acting insulins (RAIs) have been instrumental in the management of diabetes because of their improved postprandial glucose (PPG) control compared with regular human insulin. However, their absorption rate and time action following subcutaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eccc650fac1c224422fc0de05be7ce47
https://doi.org/10.1111/dom.14773
https://doi.org/10.1111/dom.14773
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To investigate the interrelations between glycaemic metrics of fasting plasma glucose (FPG), postprandial glucose (PPG), glycated haemoglobin (HbA1c), and percentage of time in target range 3.9 to 10.0 mmol/L (%TIR) in patients on insulin therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505e668dda32a5edafc25df58b83039a
http://europepmc.org/articles/PMC8252747
http://europepmc.org/articles/PMC8252747
Autor:
null Tim Heise, null Carolina Piras de Oliveira, null Rattan Juneja, null Anderson Ribeiro, null Farai Chigutsa, null Thomas Blevins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18ab78c9ba9c7677d56575cf4f33b25e
https://doi.org/10.1111/dom.14773/v2/response1
https://doi.org/10.1111/dom.14773/v2/response1
Autor:
Debra Ignaut, Jang Ik Cho, John Elpers, Farai Chigutsa, Carolina Piras de Oliveira, Ralf Klask
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33ad7b12f7babc5066e659e4dde7adf7
https://doi.org/10.1055/s-0042-1746262
https://doi.org/10.1055/s-0042-1746262
Autor:
Carolina Piras De Oliveira, Rosirene Paczkowski, Jang Ik Cho, Rattan Juneja, Jiat Ling Poon, Emily R Hankosky, Debra A Ignaut, Alfonso Ponce-Ibarra
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::895f655dec6ecded8b4440d52ac60b22
https://doi.org/10.1055/s-0042-1746260
https://doi.org/10.1055/s-0042-1746260
Autor:
Jieling Chen, Carolina Piras De Oliveira, Magaly Perez-Nieves, Matthias Blüher, Barbara Thun, Nanette C. Schloot, Erik Spaepen, Beatrice Osumili, Paul T. Williams, Jiat-Ling Poon
Publikováno v:
Diabetes Therapy
Introduction The study was designed to assess patient satisfaction, preferences and injection habits for patients using insulin lispro 200 units/ml pen (IL200) compared to their previously used disposable 100 units/ml mealtime insulin pen (“MTI-100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ceed07daa7587c03e43527609ec910
https://pubmed.ncbi.nlm.nih.gov/34542865
https://pubmed.ncbi.nlm.nih.gov/34542865
Autor:
Andrea Goldyn, Rosirene Paczkowski, Carolina Piras De Oliveira, Debra A. Ignaut, Emily R. Hankosky, Jiat Ling Poon, Jang Ik Cho
Publikováno v:
Diabetes. 70
Background: In PRONTO-Pump-2, a Phase 3, 16-week, randomized, double-blind clinical trial in patients with type 1 diabetes on continuous subcutaneous insulin infusion, ultra rapid lispro (URLi) showed superior postprandial glucose control and noninfe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b150a2d74c2480d9fb45f6d40789e504
https://doi.org/10.2337/db21-43-lb
https://doi.org/10.2337/db21-43-lb
Publikováno v:
Diabetes. 70
Background: In phase 3 trials, ultra rapid lispro (URLi) showed superior postprandial glucose control and non-inferior HbA1c reduction compared to Humalog® (Lispro). However, infusion site reactions (combined; ISRs) were more frequent with URLi. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::132aaf96290126e3f0ed6ee6e78ae1f2
https://doi.org/10.2337/db21-104-lb
https://doi.org/10.2337/db21-104-lb